Lifitegrast

FDA Drug Profile — Xiidra, Lifitegrast

Lifitegrast is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including Xiidra, Lifitegrast. Available dosage forms: solution/ drops, powder, for solution.

Drug details

Generic Name
Lifitegrast
Brand Names
Xiidra, Lifitegrast
Application Number
NDA208073
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
15
Dosage Forms
SOLUTION/ DROPS, POWDER, FOR SOLUTION
Routes
OPHTHALMIC
Active Ingredients
LIFITEGRAST

Indications and Usage

1 INDICATIONS AND USAGE Xiidra ® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Xiidra (lifitegrast ophthalmic solution) 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.